Baker McKenzie advises KD Pharma Group on the acquisition of the marine lipids business of dsm-firmenich in exchange for a minority stake in the company

Baker McKenzie has advised KD Pharma Group, a global producer of pharmaceutical and nutritional lipids, on the acquisition of dsm-firmenich's marine lipids business in exchange for a minority stake in KD Pharma Group. The transaction is expected to close towards the end of 2024 and is subject to customary regulatory approvals.

The transaction includes dsm-firmenich's Marine Lipids fish oil omega-3 business for the food and beverage, dietary supplements and pharmaceutical markets, together with the MEG-3® brand and the production facilities in Piura/Peru and Mulgrave/Canada.

"Our global team was able to successfully advise our client on this cross-border transaction and bring it closer to its goal of being the technology leader in lipids," comments Dr Tino Marz, lead partner of this transaction.

The KD Pharma Group is a leading manufacturer of active ingredients for omega-3 pharmaceuticals and omega-3 dietary supplements as well as formulation and encapsulation services. With more than 500 employees, the group is represented in the UK, Norway, Germany, Switzerland and the USA.

dsm-firmenich is a Swiss-Dutch company, listed on Euronext Amsterdam, that operates in almost 60 countries with around 30,000 employees and generates sales of more than 12 billion euros.

Baker McKenzie's Corporate/M&A practice regularly advises on domestic and international transactions. Most recently, Baker McKenzie advised Saab on a new investment in Helsing, Freaks 4U Gaming on strategic acquisition by NODWIN Gaming, Trane Technologies on strategic investment in Trailer Dynamics, AURELIUS on the acquisition of Dayco Propulsion Solutions, EQT Life Sciences on a EUR 128 million Series B2 financing of Tubulis GmbH, Knorr-Bremse AG on the sale of a majority stake in Kiepe Electric GmbH, Transcom on its acquisition of timeframe, Sika AG on its acquisition of MBCC Group from Lone Star and sale of MBCC's concrete admixtures business to Cinven, Senwes Ltd on the acquisition of four agricultural machinery dealers in the federal states of former East Germany, AURELIUS on the acquisition of LSG Group from Deutsche Lufthansa AG, Nokian Tyres plc on the sale of its Russian business to Tatneft PJSC, First Solar on the sale of its global O&M business to NovaSource and Fluidra on the acquisition of the Meranus Group.

Legal advisor to KD Pharma Group:
Baker McKenzie

Lead: Corporate/M&A: Dr Tino Marz (partner, Munich)

Team: Corporate/M&A: Liliana Espinosa (partner, Lima), Eva Kriechbaumer (senior associate, Munich), Erik Kuhn (associate, Munich), Jan Neumann (associate, Munich), Katherine Zapata (associate, Lima), Cosima König-Mancini (senior associate, Milan)
Tax: Thomas Gierath (partner, Munich)
Antitrust & Competition: Jan Kresken (partner, Düsseldorf), Roger Thomi (partner, Zurich), Markus Mossmann (associate, Düsseldorf)
IP: Patrick Wilkening (partner, Düsseldorf), Dr Moritz Sutterer (associate, Munich), Nadine Charrière (associate, Zurich)
Dispute Resolution: Cédric Pittet (associate, Zurich)
Commercial & Trade: Katharina Spenner (partner, Munich), Joachim Fröhlich (counsel, Munich)
Real Estate: Ricardo Canepa (senior associate, Lima)
Employment: Christian Koops (partner, Munich)
Natural Resources & Environmental Law: Nicole Freire (senior associate, Lima)

Public link

Please use the above public link if you want to share this noodl on another website.